OBJECTIVE: To compare patterns of gray matter loss in subjects with mutations in the progranulin (PGRN) gene to subjects with mutations in the microtubule-associated protein tau (MAPT) gene. METHODS: We identified all subjects seen at the Mayo Clinic, Rochester, MN, who had screened positive for mutations in PGRN or MAPT and had a head MRI. Twelve cases with mutations in the PGRN gene were matched by time from disease onset to scan to 12 subjects with mutations in the MAPT gene. Voxel-based morphometry was used to assess patterns of gray matter loss in the PGRN and MAPT groups compared to a control cohort, and compared to each other. MAPT subjects were younger than the PGRN subjects; therefore, each group was also compared to a specific age-matched control group. RESULTS: Both PGRN and MAPT groups showed gray matter loss in frontal, temporal, and parietal lobes compared to controls, although loss was predominantly identified in posterior temporal and parietal lobes in PGRN and anteromedial temporal lobes in MAPT. The MAPT group had greater loss compared to healthy subjects of the same age than the PGRN subjects when compared to healthy subjects of the same age. The MAPT subjects showed greater gray matter loss in the medial temporal lobes, insula, and putamen than the PGRN subjects. CONCLUSION: These results increase understanding of the biology of these disorders and suggest that patterns of atrophy on MRI may be useful to aid in the differentiation of groups of PGRN and MAPT mutation carriers.
OBJECTIVE: To compare patterns of gray matter loss in subjects with mutations in the progranulin (PGRN) gene to subjects with mutations in the microtubule-associated protein tau (MAPT) gene. METHODS: We identified all subjects seen at the Mayo Clinic, Rochester, MN, who had screened positive for mutations in PGRN or MAPT and had a head MRI. Twelve cases with mutations in the PGRN gene were matched by time from disease onset to scan to 12 subjects with mutations in the MAPT gene. Voxel-based morphometry was used to assess patterns of gray matter loss in the PGRN and MAPT groups compared to a control cohort, and compared to each other. MAPT subjects were younger than the PGRN subjects; therefore, each group was also compared to a specific age-matched control group. RESULTS: Both PGRN and MAPT groups showed gray matter loss in frontal, temporal, and parietal lobes compared to controls, although loss was predominantly identified in posterior temporal and parietal lobes in PGRN and anteromedial temporal lobes in MAPT. The MAPT group had greater loss compared to healthy subjects of the same age than the PGRN subjects when compared to healthy subjects of the same age. The MAPT subjects showed greater gray matter loss in the medial temporal lobes, insula, and putamen than the PGRN subjects. CONCLUSION: These results increase understanding of the biology of these disorders and suggest that patterns of atrophy on MRI may be useful to aid in the differentiation of groups of PGRN and MAPT mutation carriers.
Authors: Matthew L Senjem; Jeffrey L Gunter; Maria M Shiung; Ronald C Petersen; Clifford R Jack Journal: Neuroimage Date: 2005-04-12 Impact factor: 6.556
Authors: Keith A Josephs; Zeshan Ahmed; Omi Katsuse; Joseph F Parisi; Bradley F Boeve; David S Knopman; Ronald C Petersen; Peter Davies; Ranjan Duara; Neill R Graff-Radford; Ryan J Uitti; Rosa Rademakers; Jennifer Adamson; Matthew Baker; Michael L Hutton; Dennis W Dickson Journal: J Neuropathol Exp Neurol Date: 2007-02 Impact factor: 3.685
Authors: Zoe Arvanitakis; Robert J Witte; Dennis W Dickson; Yoshio Tsuboi; Ryan J Uitti; Jerzy Slowinski; Michael L Hutton; Siong-Chi Lin; Bradley F Boeve; William P Cheshire; Robert A Pooley; Julie M Liss; John N Caviness; Audrey J Strongosky; Zbigniew K Wszolek Journal: Parkinsonism Relat Disord Date: 2006-12-29 Impact factor: 4.891
Authors: Jennifer L Whitwell; Clifford R Jack; Matthew Baker; Rosa Rademakers; Jennifer Adamson; Bradley F Boeve; David S Knopman; Joseph F Parisi; Ronald C Petersen; Dennis W Dickson; Michael L Hutton; Keith A Josephs Journal: Arch Neurol Date: 2007-03
Authors: Marc Cruts; Ilse Gijselinck; Julie van der Zee; Sebastiaan Engelborghs; Hans Wils; Daniel Pirici; Rosa Rademakers; Rik Vandenberghe; Bart Dermaut; Jean-Jacques Martin; Cornelia van Duijn; Karin Peeters; Raf Sciot; Patrick Santens; Tim De Pooter; Maria Mattheijssens; Marleen Van den Broeck; Ivy Cuijt; Krist'l Vennekens; Peter P De Deyn; Samir Kumar-Singh; Christine Van Broeckhoven Journal: Nature Date: 2006-07-16 Impact factor: 49.962
Authors: Jennifer L Whitwell; Keith A Josephs; Martin N Rossor; John M Stevens; Tamas Revesz; Janice L Holton; Safa Al-Sarraj; Alison K Godbolt; Nick C Fox; Jason D Warren Journal: Arch Neurol Date: 2005-09
Authors: J S Snowden; S M Pickering-Brown; I R Mackenzie; A M T Richardson; A Varma; D Neary; D M A Mann Journal: Brain Date: 2006-09-26 Impact factor: 13.501
Authors: Matt Baker; Ian R Mackenzie; Stuart M Pickering-Brown; Jennifer Gass; Rosa Rademakers; Caroline Lindholm; Julie Snowden; Jennifer Adamson; A Dessa Sadovnick; Sara Rollinson; Ashley Cannon; Emily Dwosh; David Neary; Stacey Melquist; Anna Richardson; Dennis Dickson; Zdenek Berger; Jason Eriksen; Todd Robinson; Cynthia Zehr; Chad A Dickey; Richard Crook; Eileen McGowan; David Mann; Bradley Boeve; Howard Feldman; Mike Hutton Journal: Nature Date: 2006-07-16 Impact factor: 49.962
Authors: D C Perry; J L Whitwell; B F Boeve; V S Pankratz; D S Knopman; R C Petersen; C R Jack; K A Josephs Journal: Eur J Neurol Date: 2012-01-28 Impact factor: 6.089
Authors: J L Whitwell; S D Weigand; J L Gunter; B F Boeve; R Rademakers; M Baker; D S Knopman; Z K Wszolek; R C Petersen; C R Jack; K A Josephs Journal: Neurology Date: 2011-07-13 Impact factor: 9.910
Authors: J L Whitwell; C R Jack; B F Boeve; J E Parisi; J E Ahlskog; D A Drubach; M L Senjem; D S Knopman; R C Petersen; D W Dickson; K A Josephs Journal: Neurology Date: 2010-11-23 Impact factor: 9.910
Authors: Keith A Josephs; Jennifer L Whitwell; Stephen D Weigand; Matthew L Senjem; Bradley F Boeve; David S Knopman; Glenn E Smith; Robert J Ivnik; Clifford R Jack; Ronald C Petersen Journal: Brain Date: 2011-01-20 Impact factor: 13.501
Authors: Enrico Premi; Vince D Calhoun; Matteo Diano; Stefano Gazzina; Maura Cosseddu; Antonella Alberici; Silvana Archetti; Donata Paternicò; Roberto Gasparotti; John van Swieten; Daniela Galimberti; Raquel Sanchez-Valle; Robert Laforce; Fermin Moreno; Matthis Synofzik; Caroline Graff; Mario Masellis; Maria Carmela Tartaglia; James Rowe; Rik Vandenberghe; Elizabeth Finger; Fabrizio Tagliavini; Alexandre de Mendonça; Isabel Santana; Chris Butler; Simon Ducharme; Alex Gerhard; Adrian Danek; Johannes Levin; Markus Otto; Giovanni Frisoni; Stefano Cappa; Sandro Sorbi; Alessandro Padovani; Jonathan D Rohrer; Barbara Borroni Journal: Neuroimage Date: 2019-02-01 Impact factor: 6.556
Authors: Jennifer L Whitwell; Clifford R Jack; Matthew L Senjem; Joseph E Parisi; Bradley F Boeve; David S Knopman; Dennis W Dickson; Ronald C Petersen; Keith A Josephs Journal: Neurodegener Dis Date: 2009-03-19 Impact factor: 2.977
Authors: J L Whitwell; C R Jack; B F Boeve; M L Senjem; M Baker; R J Ivnik; D S Knopman; Z K Wszolek; R C Petersen; R Rademakers; K A Josephs Journal: Neurology Date: 2009-09-29 Impact factor: 9.910
Authors: K A Josephs; J L Whitwell; D S Knopman; B F Boeve; P Vemuri; M L Senjem; J E Parisi; R J Ivnik; D W Dickson; R C Petersen; C R Jack Journal: Neurology Date: 2009-11-03 Impact factor: 9.910
Authors: Jonathan D Rohrer; Gerard R Ridgway; Marc Modat; Sebastien Ourselin; Simon Mead; Nick C Fox; Martin N Rossor; Jason D Warren Journal: Neuroimage Date: 2010-01-04 Impact factor: 6.556